Latest news

Thumbnail image for Teva, Regeneron’s fasinumab hits osteoarthritis goals

Teva, Regeneron’s fasinumab hits osteoarthritis goals

Teva and Regeneron Pharmaceuticals have unveiled positive topline results from a Phase III study assessing the safety and efficacy of fasinumab in patients with chronic pain from osteoarthritis (OA) of the knee or hip.

17th August 2018

Thumbnail image for Lenvima wins green light in liver cancer

Lenvima wins green light in liver cancer

Eisai and MSD’s Lenvima (lenvatinib) has been approved in the US for the first-line treatment of patients with unresectable hepatocellular carcinoma (HCC).

17th August 2018

Thumbnail image for Ortho resubmits Duobrii in the US

Ortho resubmits Duobrii in the US

Bausch Health group Ortho Dermatologics has resubmitted an application to market its plaque psoriasis lotion Duobrii in the US

16th August 2018

Thumbnail image for Lancet publishes PhIII data on Kyowa Hakko’s Poteligeo

Lancet publishes PhIII data on Kyowa Hakko’s Poteligeo

The Lancet has published data from Kyowa Hakko Kirin Co’s successful Phase III trial of immunotherapy Poteligeo underpinning its recent approval in the US to treat in patients with cutaneous T-cell lymphoma (CTCL).

15th August 2018

Thumbnail image for Four new medicines cleared for use on NHS Scotland

Four new medicines cleared for use on NHS Scotland

The Scottish Medicines Consortium has approved funding for four newly licensed medicines, expanding NHS treatments options in Scotland for ovarian cancer, lung cancer, urea cycle disorders and acute hereditary angioedema.

14th August 2018

Thumbnail image for Motif Bio’s antibiotic granted US priority review

Motif Bio’s antibiotic granted US priority review

US regulators have accepted for review a targeted, Gram-positive investigational antibiotic developed by UK biopharma Motif Bio for the treatment of acute bacterial skin and skin structure infections (ABSSSI).

14th August 2018

Previous  --   9 10 11 12 13 14 15 16 17 18   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download